Mylan Institutional, Inc. (d.b.a. UDL Laboratories Recall: Clonazepam Tablets, USP, 1.0 mg
Mylan Institutional, Inc. (d.b.a. UDL Laboratories Recall: Clonazepam Tablets, USP, 1.0 mg is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Mylan Institutional, Inc. (d.b.a. UDL Laboratories); Product: Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 bl
| Recalling firm | Mylan Institutional, Inc. (d.b.a. UDL Laboratories) |
|---|---|
| Product | Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, NDC 51079-882-20 |
| Reason for recall | Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20160928 |
| Recall number | D-0136-2017 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →